An approach to gut microbiota profile in children with autism spectrum disorder by Andreo-Martínez, Pedro et al.
This article has been accepted for publication and undergone full peer review but has not been 
through the copyediting, typesetting, pagination and proofreading process which may lead to 
differences between this version and the Version of Record. Please cite this article as doi: 
10.1111/1758-2229.12810 
 
An approach to gut microbiota profile in children with autism spectrum 
disorder 
Authors 
Pedro Andreo-Martínez a,b*, Nuria García-Martínez a,, Elvira Pilar Sánchez-Samper c,d, 
Agustín Ernesto Martínez-González e*, 
 
a Department of Agricultural Chemistry, Faculty of Chemistry. University of Murcia. Campus 
of Espinardo. 30100 Murcia, Spain. 
b Department of Chemical Engineering, Faculty of Chemistry. University of Murcia, Campus 
of Espinardo, 30071 Murcia, Spain. 
c Research group of Human Nutrition & Food Sciences (NUTBRO), Veterinary Faculty, 
Regional Campus of International Excellence “Campus Mare Nostrum”, University of 
Murcia, Spain. 
d Murcian Institute of Biosanitary Research Virgen de la Arrixaca (IMIB), AREA 3, 
Digestive and Endocrine-Metabolic Diseases, Nutrition research line, Murcia, Spain. 
e Department of Developmental Psychology and Didactics, University of Alicante, Alicante, 
Spain. 
 












In recent years, there has been an increase in studies on the implications of gut microbiota 
(GM) on the behavior of children with autism spectrum disorders (ASD) due to a dysbiosis in 
GM that can trigger onset, development or progression of ASD through the microbiota-gut-
brain axis. The aim of this study is to carry out a systematic review of articles from the last 6 
years that analyze GM in children with ASD compared to GM in control groups. Children 
with ASD showed higher abundance of Roseburia and Candida genera, and lower abundance 
of Dialister, Bilophila, Veillonella, Streptococcus, Coprococcus and Prevotella genera. Those 
differences can be attributed to factors such as different nationalities, nature of control 
groups, place where the sample was taken, gastro-intestinal (GI) problems or bacterial 
detection methods. It is still too early to define a specific GM profile of children with ASD, 
and future studies should focus on homogenizing the characteristics of samples and control 
groups. Further, new multicenter studies should also focus on the impact of GM on: GI 
physiology, neurophysiology and behavior of children with ASD, and on performing 
psychometric analyses of the correlation between the severity of ASD behavioral symptoms 
and GM profiles. 
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Gut microbiota (GM) represents about 99% of the entire human microbiome (Frye et 
al., 2017). It weighs approximately 1 kg (containing about 9.9 million  bacterial genes) (Li et 
al., 2017), and it is composed of: 92.9% bacteria, 0.5% eukaryotes, 0.8% archaeas and 5.8% 
viruses (Arumugam et al., 2011). Gut microbiota abundance ranges from about 108 bacteria/g 
measured in ileum to ~1011 bacteria/g measured in stool (Sender et al., 2016), with 
Bacteroidetes, Firmicutes, Proteobacteria, Actinobacteria, and Fusobacteria being the major 
bacterial phyla in the mammalian gastro-intestinal (GI) tract (Hill et al., 2010). Recently, the 
development of human GM at the phylogenetic level has been related to the type of food 
intake and the preparation methods (e.g. food cooked on fire or boiled) (Danchin, 2018). 
However, there are cultural and geographical differences in GM composition. Prevotella, 
Proteobacteria, Spirochaetes, Clostridiales and Ruminobacter, were highly abundant in the 
gut microbiota of the hunter-gatherer populations, while those of urban communities are 
often enriched in Bacteroides, Bifidobacterium, and Firmicutes. There are also variations in 
the composition of GM between different nationalities and latitudes (Lindström and 
Langenheder, 2012; Suzuki and Worobey, 2014; Gupta et al., 2017; Cerdo et al., 2018).  




GM may play an important role in the production of several metabolites such as 
propionic acid (PPA), other short chain fatty acids (SCFAs), and gaseous molecules, which 
can induce effects on the GI tract, brain and behavior (MacFabe, 2015). These metabolites 
can produce effects via biochemical, immunological, and neuroendocrine mechanisms that 
involve endogenous and microbial modulators and transmitters (Frye et al., 2017). Changes 
in redox signaling, epigenetic transcriptional factors, lipid and mitochondrial metabolism, ion 
channel/gap junction/transporter regulation protein, and post-translational modification have 
also been reported (Frye et al., 2016; Rose et al., 2017). In addition, other biomarkers such as 
serotonin, p-cresol and cortisol have also been related to etiology and behavior in mental 
disorders such as Autism Spectrum Disorder (ASD) (Yang et al., 2015; Ferguson et al., 2016; 
Ooi et al., 2017; Kang et al., 2018). 
Recent studies have indicated that it is necessary to continue investigating the 
interaction between GM and the epithelial cells of the GI tract because GM seems to act as an 
epigenetic regulator of several diseases (Kumar et al., 2014). Thus, dysbiosis or imbalances 
in the GM can induce intestinal inflammation that is associated with the pathogenesis of 
several diseases such as obesity, Crohn’s disease, irritable bowel syndrome, Obsessive-
Compulsive Disorder, Depression, Anxiety, type 2 diabetes mellitus and neurodegenerative 
diseases including Alzheimer’s and ASD (Durbán et al., 2012; Mangiola et al., 2016; 
Schäffler et al., 2016; Ding et al., 2017; Pradhan et al., 2017; Sanchez-Samper et al., 2017). 
GM maturation occurs during the first years of life, coinciding with the critical 
window of early brain development and, at the third year of life, the GM of children is similar 
to that of adults (Diaz Heijtz, 2016). It is also known that the microbiota may continue to 




develop into adolescence (Hollister et al., 2015). In this sense, the first years of  life  are an 
important period for the appearance of neurodevelopmental disorders (Borre et al., 2014). At 
present, the microbiota-gut-brain axis is an explanatory model that attempts to relate, among 
others, ASD symptoms with findings in neuroscience and bacteriology. The microbiota-gut-
brain axis is defined as a bi-directional communication system between the neuronal, 
immune, endocrine and metabolic pathways, but it still requires better understanding (Sudo et 
al., 2004; Hiippala et al., 2016; Kantarcioglu et al., 2016). 
In recent years, there has been an increase in studies indicating a higher prevalence of 
GI problems in children with ASD compared to healthy children. Specifically, children with 
ASD have higher rates of diarrhea, constipation and abdominal pain (McElhanon et al., 2014; 
Krajmalnik-Brown et al., 2015; Martínez-González and Andreo-Martínez, 2019). Thus, 
children with ASD and with GI problems exhibit more irritability and  agitated behavior than 
children with ASD who do not have GI problems (Rose et al., 2018). On the other hand, 
some studies indicate that children with ASD present feeding problems. Specifically, they 
have a greater sensitivity to certain foods or food allergies (Xu et al., 2018) and they have a 
significantly lower intake of calcium and protein (McElhanon et al., 2014). However, the 
etiology of the nutritional and GI problems of ASD remains unknown (McElhanon et al., 
2014; Ferguson et al., 2016; Martínez-González and Andreo-Martínez, 2019) and everything 
seems to indicate that it is a combination of associated factors (Buie, 2015). Other authors 
suggest that abnormal GM in ASD may be caused by  the overuse of antibiotics (Sandler et 
al., 2000; Krajmalnik-Brown et al., 2015; Wimberley et al., 2018) or a pathophysiological 
cascade of interactions between environmental factors and key genes. In addition, the 




neurological alterations associated with atypical growth of the head  in children with ASD 
during the uterine period, which occurs more frequently in late gestations, can also be a 
possible trigger of ASD (Bonnet-Brilhault et al., 2018). 
A recent review up to 2013 reported the different gut microbes involved in ASD 
(Ding et al., 2017).  It seems that higher abundance of Clostridium (Clostridium 
clostridioforme or Clostridium bolteae) and Sutterella genera have been found in children 
with ASD and with GI problems, while lower levels of Prevotella genus have been found in 
children with ASD. A more recent systematic review up to 2018 reported elevated abundance 
of Proteobacteria, Lactobacillus, Bacteroides, Desulfovibrio, and Clostridium, and decreased 
abundance of Bifidobacterium, Blautia, Dialister, Prevotella, Veillonella, and Turicibacter in 
children with ASD compared to healthy controls (Liu et al., 2019). There are also other 
studies and previous reviews in scientific literature about GM and ASD (Wang et al., 2011; 
Cao et al., 2013; De Angelis et al., 2015; Krajmalnik-Brown et al., 2015; Andreo-Martínez et 
al., 2019; Martínez-González and Andreo-Martínez, 2019). Although there have been 
advances in the study of GM in ASD (Ding et al., 2017; Liu et al., 2019), the latest review 
studies have not been conducted following the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2015) within the past six 
years. Consequently, this study aims to conduct an updated systematic review of the findings 
of the most common bacterial populations and their abundance in the GM of children with 
ASD compared to control groups. We expect to find some bacterial population patterns in 
children with ASD compared to children who do not have this disorder. 




The method followed to carry out the present systematic review is described in detail 




Dysbiosis of the GM in ASD 
Table 1 shows the twenty-one articles included in the present systematic review and 
the results of the analysis of the samples of children with ASD. The gut microbes that showed 
significantly different abundance in ASD at phylum, family, genus, and specie levels, 
according to the articles found in the present review, are listed in Figure 2. The phylogenetic 
tree of this figure was drawn with the help of the Interactive Tree Of Life (iTOL) web-based 




Gut microbiota dysbiosis found in ASD  
Nineteen articles found significant differences in some gut microbes’ abundance in 
children with ASD (Table 1) compared to their respective control groups. Specifically, there 
are 6 bacteria phyla, 16 bacterial families, 1 presumptive bacterial family, 48 bacterial 
genera, 4 presumptive bacterial genera groups, 1 presumptive bacterial genus and 19 bacterial 
species of Bacteria domain, and one genus of the Fungi kingdom.  




Two studies found no differences in the GM composition of children with ASD 
(Gondalia et al., 2012; Son et al., 2015). Therefore, the present review expands upon the 
number of bacteria previously reported (Cao et al., 2013; Ding et al., 2017; Liu et al., 2019). 
Of note, the recent systematic review published by Liu et al. (2019) reported on different 
articles from those included in the present systematic review, as they used different 
inclusion/exclusion criteria such as the inclusion of articles that only analyzed GM by 
culture-independent methods or the time-frame chosen (from inception to March 2018).In 
addition, some works have shown contradictory results regarding the nature and/or extent of 
GM abundance in children with ASD as discussed by Krajmalnik-Brown et al. (2015) and 
Liu et al. (2019).  
The gut microbe abundance of two bacterial phyla, 4 bacterial families, 19 bacterial 
genera, one genus of the Fungi kingdom and two bacterial species, were found to be 
significantly different in children with ASD compared to their control groups by more than 
one article. Among those gut microbes, the abundance of 7 bacterial genera and Candida 
were reported to be similar, while the rest showed abundance discrepancies (Table 1). 
The highest number of GM components studied by more than one article was found in 
Firmicutes phylum (12), followed by Actinobacteria phylum (5), Bacteroidetes phylum (4) 
and, Proteobacteria phylum (2) and the Deuteromycota phylum (1).  
 
High abundance of some gut microbes in ASD 
One bacterial phylum, eight bacterial families, one presumptive bacterial family, 
thirteen bacterial genera, two presumptive bacterial genera groups, one fungi genus, and 




twelve bacterial species were found to have statistically significant higher abundance in 
children with ASD compared to their control groups. Specifically, at phylum level: 
Proteobacteria (Coretti et al., 2018) were found to have statistically significant higher 
abundance in children with ASD compared to their control groups. At family level: 
Lactobacillaceae, Enterococcaceae, Erysipelotrichaceae and Desulfovibrionaceae (Pulikkan 
et al., 2018), Peptostreptococcaceae (Berding and Donovan, 2018), Bacteroidaceae, 
Lachnospiraceae and Ruminococcaceae (Rose et al., 2018), and presumptive 
Enterobacteriaceae (De Angelis et al., 2013) were found to have statistically significant 
higher abundance in children with ASD compared to their control groups. At genus level: 
Porphyromonas, presumptive Bacteroides, Porphyromonas and Prevotella, Caloromator, 
Sarcina, Anaerofilum, presumptive Pseudomonas and Aeromonas, and Shigella (De Angelis 
et al., 2013), Ruminococcus and Lachnospira (Coretti et al., 2018), Collinsella (Strati et al., 
2017), Mitsuokella and Megasphaera (Pulikkan et al., 2018), Burkholderia (Kushak et al., 
2017), Roseburia (De Angelis et al., 2013; Berding and Donovan, 2018; Coretti et al., 2018), 
Peptostreptococcus and Ralstonia (Kushak et al., 2017), and Candida (Iovene et al., 2017; 
Strati et al., 2017) were found to have statistically significant higher abundance in children 
with ASD compared to their control groups. At species level: Bilophila wadsworthia, 
Flavonifractor plautii, Roseburia intestinalis, Lachnoclostridium boltae, Lachnoclostridium 
hathewayi, Oscillospira valericigenes, Clostridium lituseburense and Clostridium aldenense 
(Luna et al., 2017), Ruminococcus gnavus and Ruminococcus torques (Wang et al., 2013), 
Lactobacillus ruminis (Pulikkan et al., 2018), and Akkermansia muciniphila (De Angelis et 




al., 2013) were found to have statistically significant higher abundance in children with ASD 




 Low abundance of some gut microbes in ASD 
Three bacterial phyla, four bacterial families, twenty-two bacterial genera, one 
presumptive bacterial genus, two presumptive bacterial genera groups, and five bacterial 
species were found to have statistically significant lower abundance in children with ASD 
compared to their control groups. Specifically, at phylum level: Fusobacteria, Verrumicrobia 
(De Angelis et al., 2013), and Actinobacteria (Coretti et al., 2018). At family level: 
Rikenellaceae (Berding and Donovan, 2018), Actinomycetaceae, Streptococcaceae and 
Gemellaceae (Coretti et al., 2018). At genus level: Fusobacterium, Eubacterium, 
Subdoligranulum, Enterococcus, Turicibacter, presumptive Staphylococcus, presumptive 
Streptococcus and Lactococcus, and presumptive Enterococcus and Lactobacillus (De 
Angelis et al., 2013), Alistipes (Strati et al., 2017), Dialister and Bilophila (Strati et al., 2017; 
Berding and Donovan, 2018), Eggerthella (Coretti et al., 2018), Peptoniphilus, Parvimonas, 
Bulleida and Escherichia (Zhang et al., 2018), Haemophilus (Kang et al., 2018), Neisseria 
(Kushak et al., 2017), Coprococcus (Kang et al., 2013; Coretti et al., 2018), Veillonella (Strati 
et al., 2017; Zhang et al., 2018), Prevotella (De Angelis et al., 2013; Kang et al., 2013; 
Kushak et al., 2017), Streptococcus (De Angelis et al., 2013; Inoue et al., 2016; Kushak et al., 
2017; Coretti et al., 2018; Zhang et al., 2018), Butyricimonas and Butyrivibrio (Berding and 




Donovan, 2018), and Devosia (Kushak et al., 2017). At species level: Bacteroides vulgatus, 
unidentified Bacteroides and Escherichia coli (Kushak et al., 2017), Prevotella copri and 
Haemophilus parainfluenzae (Kang et al., 2018). 
 
Sample characteristics and other parameters studied 
Among the 21 articles found in the present systematic review, none of them studied 
the communities of viruses and protozoa. Only two articles reported data about Fungi 
community (Iovene et al., 2017; Strati et al., 2017).  
Place where the sample was taken 
Three articles analyzed the GM in biopsies taken from the GI tract (Williams et al., 
2012; Kushak et al., 2017; Luna et al., 2017), while the rest of the articles analyzed the GM 
in feces samples.  
 
Bacterial detection methods 
Seventeen articles used culture-independent methods (16S rRNA pyrosequencing of 
bacterial genes or PCR-based detection), three articles used culture-dependent methods 
(Finegold et al., 2017; Iovene et al., 2017; Gora et al., 2018), and one article used both 
methods (De Angelis et al., 2013). In this sense, De Angelis et al. (2013) used culture-
dependent and culture-independent methods, finding no differences in the abundance of some 
gut microbes between both methods as reported elsewhere (Alinovi et al., 2009).  The case of 
Candida was similar,  as higher abundance of this bacterial genus was found in Italian 
children with ASD using culture-dependent (Iovene et al., 2017) and culture-independent 




(Strati et al., 2017) methods. However, in the case of Lactobacillus and Clostridium the 
results obtained by different authors using both methods were contradictory.  
Among the eighteen articles using culture-independent methods, three used qPCR 
(Wang et al., 2013; Tomova et al., 2015; Shaaban et al., 2017), three used both qPCR and 
pyrosequencing of the 16S rRNA gene bacterial (Williams et al., 2012; Kang et al., 2013; 
Son et al., 2015) and the remaining 12 articles used only pyrosequencing of the 16S rRNA 
gene bacterial. Among the 15 articles using pyrosequencing of the 16S rRNA gene bacterial 
method, five used pyrosequencing of the 16S rRNA gene bacterial (V3-V4 region) (Inoue et 
al., 2016; Berding and Donovan, 2018; Coretti et al., 2018; Rose et al., 2018; Zhang et al., 
2018), three used pyrosequencing of the 16S rRNA gene bacterial (V1-V3 region) (Gondalia 
et al., 2012; De Angelis et al., 2013; Kushak et al., 2017), two used pyrosequencing of the 
16S rRNA gene bacterial (V2-V3 region) (Kang et al., 2013; Kang et al., 2018), one used 
pyrosequencing of the 16S rRNA gene bacterial (V3-V5 region) (Strati et al., 2017), one used 
pyrosequencing of the 16S rRNA gene bacterial (V1-V2 and V1-V3 region) (Son et al., 2015), 
one used pyrosequencing of the 16S rRNA gene bacterial (V1-V3 and V4 region) (Luna et al., 
2017), one used pyrosequencing of the 16S rRNA gene bacterial (V2 region) (Williams et al., 
2012) and one used pyrosequencing of the 16S rRNA gene bacterial (V3 region) (Pulikkan et 
al., 2018). Taking into account the five articles using pyrosequencing of the 16S rRNA gene 
bacterial (V3-V4 region) method, higher abundance of Bacteroidetes and Roseburia and lower 
abundance of Actinomyces and Streptococcus were found in children with ASD compared to 
HC by more than one article. However, Firmicutes, Coriobacteriaceae, Blautia and 




Faecalibacterium showed abundance discrepancies in children with ASD compared to HC in 
more than one article. 
 
Nature of control groups 
Neurotypical (NT) children were used as the control group in four articles (Kang et 
al., 2013; Luna et al., 2017; Strati et al., 2017; Kang et al., 2018), NT siblings were used as 
the control group in two articles (Gondalia et al., 2012; Son et al., 2015), both NT siblings 
and healthy children were used as control groups in one article (Wang et al., 2013), both 
healthy siblings and healthy children were used as control groups in one article (Tomova et 
al., 2015), both Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and 
healthy siblings were used as control groups in one article (De Angelis et al., 2013), one 
article used healthy siblings as the control group (Pulikkan et al., 2018), and healthy children 
were used as the control group in the rest of the articles. Of note, NT children are defined as 
individuals without neurological, medical, or psychiatric diagnoses (Hamilton et al., 2016), 
and they can also be referred to as the healthy children group. However, differences in gut 
microbe abundance can occur when siblings or unrelated people are used as a control group 
(Krajmalnik-Brown et al., 2015). Any child could be colonized by oro-fecal transmission and, 
if predisposed  with a defective immune system, an abnormal GM related to antimicrobials 
and other factors such as genetics, could  lead to the development of ASD (Finegold et al., 
2010).  
 
Nationalities of the children studied 




 The children with ASD studied were from 9 different nationalities: American 
(Williams et al., 2012; Kang et al., 2013; Son et al., 2015; Finegold et al., 2017; Kushak et 
al., 2017; Luna et al., 2017; Berding and Donovan, 2018; Kang et al., 2018; Rose et al., 
2018), Australian (Gondalia et al., 2012; Wang et al., 2013), Chinese (Zhang et al., 2018), 
Egyptian (Shaaban et al., 2017), Indian (Pulikkan et al., 2018), Italian (De Angelis et al., 
2013; Iovene et al., 2017; Strati et al., 2017; Coretti et al., 2018), Japanese (Inoue et al., 
2016), Polish (Gora et al., 2018) and Slovakian (Tomova et al., 2015). The difference in the 
nationalities of the children with ASD is also a factor to be taken into account and it is 
important to consider that there are differences in bacteria prevalence according to the 
country due to cultural and dietary aspects, among other factors (Lindström and Langenheder, 
2012). In this sense, Firmicutes dominate the GM of the general European population 
(Tomova et al., 2015), and general American and Chinese communities showed high 
abundances of Firmicutes and Bacteroidetes, respectively (Gupta et al., 2017). In addition, 
inter-individual and regional differences have been also reported in the general population 
(Hill et al., 2010; Cerdo et al., 2018) and there is a lack of studies testing the effects of the 
Mediterranean-style diet on ASD. 
 
 
Presence of functional gastrointestinal disorders 
No functional gastrointestinal disorders (FGID) were reported in five articles (De 
Angelis et al., 2013; Inoue et al., 2016; Shaaban et al., 2017; Berding and Donovan, 2018; 
Coretti et al., 2018). Although there is a greater prevalence of GI symptoms in ASD 




(McElhanon et al., 2014; Martínez-González and Andreo-Martínez, 2019) there are studies 
reporting no FGID, as some authors excluded children with ASD and FGID in their studies 
(De Angelis et al., 2013; Strati et al., 2017; Berding and Donovan, 2018). 
 
Diagnosis of ASD severity and intellectual disability 
Two articles reported the ASD severity of the children (Iovene et al., 2017; Pulikkan 
et al., 2018) and neither of these articles indicated whether children with ASD had been 
diagnosed with an intellectual disability, which is a very important aspect that influences 
adaptive ASD behavior (Inada et al., 2015). 
 
Higher or lower abundance of gut microbes in ASD 
One bacterial genus (Roseburia) and one fungi genus (Candida) were found to have 
statistically significant higher abundance in children with ASD by more than one article 
(Table 1). Roseburia and Coprococcus genera (De Angelis et al., 2013) together with some 
ASD-associated bacteria such as the Clostridia class, and Bacteroides and Desulfovibrio 
genera (MacFabe, 2012; MacFabe, 2015) were described as capable of degrading starch and 
fermenting other carbohydrates to synthesize SCFA. Propionic acid and other SCFAs are 
mainly produced by active microbiota fermentation of vegetable fiber and/or dietary 
carbohydrates in the cecum (Nankova et al., 2014; Frye et al., 2016; Rose et al., 2017; Maji et 
al., 2018). Propionic acid and butyrate can act as colonocytes and mitochondrial fuels, and 
electrolyte absorption by colon mucosa with anti-inflammatory properties (De Angelis et al., 
2013). Propionic acid and butyrate have differential modulatory effects on mitochondrial and 




cellular function which can be complex and concentration-dependent (Frye et al., 2015) and 
can include T-cell function modulation and cytokine production (Rose et al., 2017). Indeed, 
SCFA can disrupt cellular physiology in order to cause FGID associated with ASD such as 
non-specific inflammation and dysmotility (Kang et al., 2017; Rose et al., 2017). In addition, 
butyrate can promote the synthesis of mucin and enhance intestinal tight junction integrity 
(Zhang et al., 2018). Many genera of the Lachnospiraceae family, such as Roseburia and 
Dorea, which were found to have higher abundance in Italian children with ASD, have a very 
poor capacity to degrade free amino acids (FAAs) (De Angelis et al., 2013). It has been 
reported that FAAs fecal level increases in children with ASD, especially glutamate (Glu). 
Some FAAs, particularly Glu, also act as neurotransmitters in the central nervous system, and 
a Glu excess can lead to neuronal death, so Glu has an important role in the pathophysiology 
of some neuropsychiatric disorders, including ASD (Won et al., 2012). On the other hand, 
Candida albicans was the most frequently identified Candida species in the work of Iovene 
et al. (2017). In fact, some studies have pointed out that high abundance of Candida albicans 
can cause less carbohydrate and mineral absorption, and generate higher toxin levels that 
could contribute to ASD behaviors (Kantarcioglu et al., 2016). Other authors hypothesized 
that some Lactobacillus species can modulate the immunological responses to Candida in the 
GI tract by providing tryptophan-derived aryl hydrocarbon receptor ligands that stimulate the 
immune system, principally IL-C3 cells, to produce IL-22. Together with IL-17, IL-22 
prevents the excessive proliferation of Candida and other fungal commensals (Zelante et al., 
2013; Strati et al., 2017). In other words, IL-22 allows for survival of mixed microbial 
communities yet provides a pivotal innate antifungal resistance to Candida and mucosal 




protection from inflammation (Zelante et al., 2013). In this sense, it is possible that ASD 
dysbiosis may lead to a Candida population expansion, preventing complete bacterial 
community structural restoration, as can be observed by the lower abundance of 
Lactobacillus found in Italian children with ASD and FGID compared to their HC group 
(Iovene et al., 2017),. However, higher abundance of Lactobacillus was also found in Italian 
children with ASD compared to their NT group (Strati et al., 2017). In conclusion, there is a 
clear lack of investigation of the whole Fungi kingdom in children with ASD and there is still 
little known about the  influence of Candida and other types of fungi on both GI and ASD 
symptoms (Andreo-Martínez et al., 2019). 
In addition, six bacterial genera (Prevotella, Dialister, Bilophila, Veillonella, 
Streptococcus and Coprococcus) were found by more than one article to have statistically 
significant lower abundance in children with ASD (Table 1). 
Lower abundance of Prevotella has been found in feces of Italian children with ASD 
compared to their sibling group (De Angelis et al., 2013), in feces of American children with 
ASD compared to their NT group (Kang et al., 2013), and in duodenal biopsy samples from 
the second part of the duodenum of American children with ASD compared to their HC 
group (Kushak et al., 2017). As can be observed, similar results were achieved by comparing 
two different nationalities, two different control groups and two different places where the 
sample was taken.  
It is believed that the presence of Prevotella and other Bacteroidetes are associated 
with colon health and ASD manifestations may have their origin in a dysbiosis where 
Prevotella decreases and Sutterella increases (Ding et al., 2017). In this sense, the lower 




abundance of Prevotella found in American children with ASD was associated with the 
presence of ASD symptoms instead of FGID (Kang et al., 2013). These authors found no 
correlation in a later work (Kang et al., 2018), although they found that FGID were 
significantly more severe in American children with ASD compared to their NT group. As 
Prevotella is just one genus of the GM that is very diverse and has a tendency to coexist with 
a complex collection of other bacterial species, Krajmalnik-Brown et al. (2015) tried to find 
an explanation about the lower abundance of Prevotella in American children with ASD 
compared to both Malawian and Venezuelan children with ASD. They found that Prevotella 
may act as an indicator of Westernization and this change could also be framing an altered 
immune system, but their results were not conclusive. Finally, Desulfovibrio works 
synergistically with Prevotella to degrade mucin and Desulfovibrio, Prevotella, and 
Oscillibacter can utilize microbial exopolysaccharides synthesized by Bifidobacterium to 
produce SCFA in the GI tract (Kang et al., 2013). In this sense, the lower abundance of 
Prevotella can decrease the SCFA level in the GI tract of children with ASD. 
Veillonella was less abundant in Chinese (Zhang et al., 2018) and Italian (Strati et al., 
2017) children with ASD compared to their HC and NT groups, respectively (Table 1). 
Different nationalities and similar control groups showed no differences in this bacteria 
genus. In addition, Coprococcus, Veillonellaceae and Enterococcaceae, together with 
Prevotella, are intriguingly versatile bacteria that degrade and/or ferment carbohydrates, 
suggesting that differences in microbial composition (especially in Veillonella) of children 
with ASD may be a consequence of diet (Kang et al., 2013; Pulikkan et al., 2018). Then, a 
lower abundance of Veillonella may disturb the fermentation of lactate in children with ASD, 




as this bacterial genus is capable  of fermenting lactate (Zhang et al., 2018). As Dialister is a 
bacteria belonging to the Veillonellaceae family, the aforementioned statement for 
Veillonella could be also valid  for Dialister, as  this bacterial genus also showed lower 
abundance in American (Berding and Donovan, 2018) and Italian (Strati et al., 2017) children 
with ASD compared to HC. Further, lower abundance of Dialister has been statically 
correlated with nutritional intake. Specifically, children with ASD eating 20 foods or less in 
their diet had lower intakes of pectin, vitamin C, niacin, vitamin B6, folate, and selenium, but 
higher intakes of added sugars (Berding and Donovan, 2018). Streptococcus was found to be  
less abundant in duodenal biopsy samples from the second part of the duodenum of American 
children with ASD compared to their HC group (Kushak et al., 2017), in feces of Chinese 
(Zhang et al., 2018) and Japanese (Inoue et al., 2016) children with ASD compared to their 
HC groups, respectively, and in feces of Italian children with ASD compared to their HC 
(Coretti et al., 2018) and siblings (De Angelis et al., 2013) groups, respectively, with 
Streptococcus and Enterococcus being the dominant genera of the Bacilli class in the work of 
De Angelis et al. (2013). Those results are similar even when comparing four different 
nationalities, two different control groups and two different places where the sample was 
taken. 
Streptococcus together with Lactobacillus, Bifidobacterium and Lactococcus produce 
lactate (Zhang et al., 2018). It is known that ASD patients show high levels of lactate 
(Rossignol and Frye, 2011), suggesting an increase in glycolysis through the phenomenon of 
aerobic glycolysis in ASD since the dysregulation of this balance has been proposed as a  
potential cause of ASD (Vallée and Vallée, 2018). At this point, we cannot confirm that the 




increase in lactate in people with ASD can be attributed solely to the GM since, as seen 
below, there is still no consensus regarding the abundance of certain lactate-producing 
bacteria such as Lactobacillus or Bifidobacterium.  
American children with ASD compared to their NT group (Kang et al., 2013) and 
Italian children with ASD compared to their HC group (Coretti et al., 2018) showed lower 
abundance of Coprococcus (Table 1). In this case, two different nationalities and similar 
control groups coincided in low abundances of this bacterial genus.  
Coprococcus comes was positively correlated with aerophagia and Coprococcus catus 
was negatively correlated with abdominal migraine (Luna et al., 2017), showing the role 
played by some Coprococcus species in FGID. Finally, as discussed before, Coprococcus 
also produces SCFA, suggesting that the unusual diet patterns observed in ASD children may 
be a possible influence (Kang et al., 2013).  
Bilophila is a sulfite-reducing and hydrogen sulfide-producing bacteria in the human 
GI tract which is usually difficult to detect in healthy individuals. Increased numbers of 
Bilophila in GM induce systemic inflammation and thus contributes to the onset of the 
metabolic disorders (Feng et al., 2017). The present systematic review found lower 
abundance of Bilophila in American (Berding and Donovan, 2018) and Italian (Strati et al., 
2017) children with ASD compared to HC, therefore, further research is needed regarding the 
implications of this bacterial genus in ASD. Regarding the Bacteroidetes/Firmicutes ratio in 
the GI tract of children with ASD, it  is characterized by  a lower Bacteroidetes/Firmicutes 
ratio in Italian, Slovakian, and Indian children with ASD compared to their heterogenous 
control groups (De Angelis et al., 2013; Tomova et al., 2015; Strati et al., 2017; Pulikkan et 




al., 2018). However, according to Coretti et al. (2018) and Zhang et al. (2018), the 
Bacteroidetes/Firmicutes ratio  in Italian and Chinese children with ASD, respectively, was 
higher than their HC groups. As discussed before, different nationalities, control groups, the 
place where the sample was taken or bacterial detection methods can lead to contradictory 
results. In addition, Tomova et al. (2015) hypothesized that the possible reasons  for  
contradictory results in different studies can be due to participants’ age (younger people’s 
GM contain proportionally fewer Bacteroidetes), GI problems in HC, GI tract level where 
sample was taken, or geographical area. Therefore, for the correct interpretation of GM’s role 
in ASD, etiopathogenesis can be important to compare matching homogeneous groups. 
 
Possible reasons of the differences found in GM of ASD 
The differences found in GM of children with ASD can be attributed to ASD 
heterology, small sample sizes, different places where the sample were taken, different 
bacterial identification methods, different nationalities, inter-individual differences, antibiotic 
use, malnutrition, dietary habits, age of participants and nature of control groups, prebiotics 
and probiotics used, and FGID presence, among others. For example, it has been reported that 
GM communities of fecal samples are similar to luminal communities; however, significantly 
higher abundances of some gut microbes that preferentially adhere to the mucosa, such as 
Lactobacillus, compared to fecal samples have been found. Therefore, the place where the 
sample were taken can be relevant for mammalian physiology, as bacterial communities 
display differences between anatomical locations (Hill et al., 2010; Durbán et al., 2012; 
Martínez-González and Andreo-Martínez, 2019). Regarding bacterial detection methods: on 




the one hand, absolute cell abundances of culturable living microbes can be quantified using 
culture-dependent methods, although the number of microorganisms detected is limited and 
this method requires some days to obtain results. On the other hand, the use of culture-
independent methods has increased in recent years due to the fact that they can readily 
identify a large proportion of the bacterial diversity and they give fast results. In addition, 
amplification bias in heterogeneous mixtures may occur due to differences in genomic 
sequences at primer sites, 16S rRNA copy number, different bioinformatic analysis methods 
and guanine-cytosine content, such that the read counts can be correlated semi-quantitatively 
with the relative abundance of bacterial species (Gondalia et al., 2012; Salipante et al., 2013; 
Zapka et al., 2017). Therefore, future studies should use similar bacterial detection methods 
in order to minimize these biases, taking into account the fact that culture-independent 
methods are relatively new in comparison with culture-dependent methods and they are still 
developing and not yet standardized (Zapka et al., 2017). Thus, future microbial 
technological developments should combine omics data with phenotypic information to 
invoke and control specific phenotypes in the microbiome (De Vrieze and Boon, 2018). Of 
note, there are still discrepancies in the abundance of some bacteria using the same bacterial 
detection method, as discussed in section 3.2.2.  In addition, one explanation regarding the 
differences in gut microbe’s abundance when siblings or unrelated people are used as a 
control group could be that the children of both samples intake a similar diet, or the possible 
fecal bacteria transmission from children with ASD to their siblings (multiple ASD cases are 
common in families), playmates, friends, etc. resulting in similar bacterial abundance 
(Tomova et al., 2015). 






At this point, there is no consensus about a GM profile of children with ASD and 
further research is needed. In addition, an important absence in the psychometric analysis of 
the relationship between the severity of behavioral ASD symptoms and bacterial abundance 
and FGID has been found. Similarly, none of the studies indicate whether children with ASD 
have been diagnosed with an intellectual disability.  
Therefore, the results of the present systematic review encourage the need to initiate 
new multicenter studies on the impact of bacterial components of GM on: gastrointestinal 
physiology, neurophysiology, metabolomic and behavior of children with ASD. We consider 
that ASD has a wide phenotypic variability, so future studies should consider the genetic, 
phenotypic and behavioral antecedents in a more integral and interdisciplinary way. In 
addition, we consider it of great importance that future studies classify ASD groups according 
to the severity of ASD and intellectual disability. Finally, we argue that future research 
should homogenize statistical analysis in order to develop meta-analytical studies on the GM 
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Table, Figure and supporting information legends 
 
Figure 1. Flowchart showing the process of identifying relevant studies for the present 
systematic review. 
 




Figure 2. Phylogenetic map of bacterial populations (Phyla, families, genera and species 
level) in the ASD.  
Note: [A = Williams et al. (2012); B = Gondalia et al. (2012); C = Kang et al. (2013); D = 
Wang et al. (2013); E = De Angelis et al. (2013); F = Son et al. (2015); G =Tomova et al. 
(2015); H = Inoue et al. (2016); I = Strati et al. (2017); J = Iovene et al. (2017); K= Luna et 
al. (2017); L = Finegold et al. (2017); M = Kushak et al. (2017); N = Shaaban et al. (2017); O 
= Gora et al. (2018); P = Kang et al. (2018); Q = Pulikkan et al. (2018); R = Rose et al. 
(2018); S = Coretti et al. (2018); T = Zhang et al. (2018); U = Berding and Donovan (2018)]. 
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10 y (15/23 
aged 3-5 y; 














3-10 y (7/9 








the 16S rRNA 
gene pan-bacterial 
(V2 region) on 









V8 region and C4 
–V8 region) on 






soluble proteins of 
cultured Sutterella 
wadsworthensis 
Sutterella ↑ in ASD w 
FGID vs HC w FGID 
(ilea p=0.022 / ceca 
p=0.037) 
Plasma IgG or IgM 
antibody reactivity to 
Sutterella antigens in 
ASD w FGID  
ASD severity is 
not indicated 
 
It is not indicated 





























(bTEFAP) of the 
16S rRNA gene 
bacterial (V1-V3 
regions) on fecal 
samples 
No difference in 
microbiome between 
total ASD vs NT Sib. 
No difference regarding 
severity ASD in the 
bacterial composition. 
No difference regarding 
GI dysfunction in the 
bacterial composition 
(No differences within 
the ASD group 
compared to both with 
and without FGID 
groups) 
No metabolites were 
studied 
It is not indicated 





The dietary intake 

















Age 3-16 y 
 




(bTEFAP) of the 
16S rRNA gene 
bacterial (V2-V3 











↓ in ASD vs NT. 
Microbial changes were 
more closely linked to 
the presence of autistic 
symptoms rather than to 
the severity of GI 
symptoms and specific 
diet/supplement 
regimens 
No difference between 
GI severity problems and 
ASD severity indexes 
It is not indicated 





Wang et ASD (n=23) HC (n=9) qPCR for Sutterella ↑ (p=0.044) in No metabolites were ASD severity is 

















(n=22) w or 
w/o FGID 
 






torques and R. 
gnavus on fecal 
samples. 
ASD vs NT Sib. 
Sutterella ↑ (p=0.05) in 
ASD vs HC. 
Sutterella ↑ (p=0.047) in 
NT Sib vs HC. 
Ruminococcus gnavus ↑ 














Ruminococcus torques ↑ 
(p=0.008) in ASD w 
FGID (n=9) vs ASD w/o 
FGID (n=14). 
studied not indicated 
 
It is not indicated 




The dietary intake 





























(bTEFAP) of the 
16S rRNA gene 
bacterial (V1-V3 
























anaerobe agar + 








Gut microbial diversity ↑ 






Verrumicrobia ↓ in ASD 
vs HC (p<0.05) 
 
Faecalibacterium ↓ in 
ASD vs HC. 
Anaerofilum ↑,  
Oscillospira ↓,  
Subdoligranulum ↓ in 
ASD vs HC (p<0.05) 
 




Sarcina ↑ in ASD vs HC 
(p<0.05) 
 
Roseburia ↑ (p<0.05). 
Dorea ↑ in ASD vs HC 
(p<0.05) 
 
Eubacterium ↓ in ASD 
vs HC (p<0.05) 
 
Streptococcus ↓ in ASD 
vs HC (p<0.05) 
Clostridium with methyl 
esters (butanoic acid 
methyl ester, acetic acid 
methyl ester and 
pentanoic acid methyl 






total SCFAs (r=1.0; 
p<0.05) 
 
Bacteroides with total 
FAA, NH3 and PPA 
(r=1.0; p<0.05) 
ASD severity is 
not indicated 
 
It is not indicated 





















Rogosa agar + 
glacial acetic acid 
(Lactobacilli); 








series amino acid 
analyzer for 
concentration of 













Turicibacter ↓ in ASD vs 
HC (p<0.05) 
 
Bacteroides ↑ in ASD vs 
HC (p<0.05) 
 
Prevotella ↓ in ASD vs 
HC (p<0.05) 
 
Shigella ↑ in ASD vs HC 
(p<0.05) 
 
Bifidobacterium ↓ in 
ASD vs HC (p<0.05) 
 
Fusobacterium ↓ in ASD 
vs HC (p<0.05) 
 
Akkermansia 






No differences between 
PDD-NOS, ASD and HC 
for total microbes 
 
Total anaerobes were the 











Staphylococcus ↓ in 
ASD vs HC (p<0.05) 
 
Bifidobacterium ↓ in 










Enterobacteriaceae ↑ in 
ASD vs HC (p<0.05) 























into NT Sib 
w FGID 
(13/44) and 




















subgroup on fecal 
samples 
 
Sequencing of the 
16S rRNA gene 
bacterial (V1-V2 
and V1-V3 
regions) on fecal 
samples 
No difference between 
total ASD vs NT Sib in 
bacterial frequency. 
 
Increased prevalence of 
functional constipation 
FGID in ASD children 







Increased prevalence of 
functional constipation 
FGID in ASD children 
compared to NT 
siblings. 
ASD severity is 
not indicated 
 
Is not indicated 





















Sib w FGID 
(7/9) and 

































ELISA for TNF-α 










ratio↓ in ASD vs HC 
(p<0.05); ↓ Sib vs ASD 
(p<0.05); ↓ Sib vs HC 
(p<0.05) 
Firmicutes ↑ in Sib vs 
HC 
Lactobacillus ↑ in ASD 
vs HC (p<0.05) 
Bifidobacterium ↑ in 
ASD vs Sib (p<0.05) 
 
Desulfovibrio with ASD 
severity in the ADI 
restricted/repetitive 
behavior subscale score. 
 
No correlation between 
plasma levels of 
oxytocin, testosterone, 
DHEA-S and gut 
microbiota 
It is not indicated 




The dietary intake 





















Sequencing of the 
16S rRNA gene 
bacterial (V3-V4 
regions) on fecal 
samples 
Gene expression 
of PBMC by 
microarray 





Blautia ↓ in ASD vs HC 
(p<0.05) 
 
Faecalibacterium ↑ in 
ASD vs HC (p<0.05) 
Streptococcus ↓ in ASD 
vs HC 
↑Faecalibacterium and a 
greater number of 
differentially expressed 
genes involved in both 
the interferon (IFN)-γ-
mediated signaling 
pathway and the type I 
interferon signaling 
pathway, (in particular in 
the latter) 
ASD severity is 
not indicated 
 
It is not indicated 




Small number of 
participants 
 
Dietary intake was 
not controlled 














































the 16S rRNA 
gene bacterial 
(V3-V5 regions) 
and the internal 
transcribed spacer 
(ITS) for fungal 
(ITS1 rDNA 








ratio↑, Bacteroidetes ↓, 
Veillonella ↓, Alistipes ↓, 
Bilophila↓, Dialister↓, 
Parabacteroides↓ in 
ASD vs NT (p<0.005)  
 
Lactobacillus ↑, Dorea 
↑, Corynebacterium ↑, 
Collinsella ↑, Candida ↑ 
in ASD vs NT (p<0.001) 
Escherichia/Shigella and   
cluster XVIII with GI 
symptoms or 
constipation (p<0.05) 
It is not indicated 





It should be noted 
that the number of 
enrolled 
constipated 
subjects was quite 





































(c) search for 




culture and  
(e) identification 
of bacteria and 
















Candida ↑ in ASD vs 
HC (p=8.67x10-6) 
 
Lactobacillus ↓ in ASD 
vs HC (p=7.28x10-4) 
 




Leukocytes ↑ in ASD 




calprotectin with CARs 
(p=0.03) 
 
Lactulose ↑ in ASD 
µ1=0.550 vs HC 
µ2=0.249 (p=0.03) 
It is not indicated 




The dietary intake 


















Sequencing of the 
16S rRNA gene 
(V1-V3 and V4 
regions) on 
Blautia ↓ (p=0.02), 
Dorea ↓ (p=0.006), 
Sutterella ↓ (p=0.025) in 
ASD w FGID vs NT w 
IBS with ↑ Clostridium 
aldenense (p=0.04);  
 
Functional constipation 
ASD severity is 
not indicated 
 
Is not indicated 




Age 4-13 y 
 
14 males 
Age 3-18 y 











38 cytokines by 
the MagPix 
system on biopsy 


















bolteae ↑ (p=0.017), 
Lachnoclostridium 
hathewayi ↑ (p=0.03), 
Clostridium aldenense ↑ 
(p=0.03), and 
Flavonifractor plautii ↑ 
(p=0.03), in ASD w 
FGID vs NT w FGID 
and NT w/o FGID 
 
Faecalibacterium 
prausnitzii ↑, Roseburia 
intestinalis ↑, 
Oscillospira 
valericigenes ↑, and 
Bilophila wadsworthia ↑ 
(p<0.05) in NT w FGID 
vs NT w/o FGID 










Aerophagia with ↑ 
Clostridium aldenense 









ramulus (p=0.006), and 
Phascolarctobacterium 
faecium (p=0.04);  
 
Abdominal migraine 















hathewayi (p=0.003) and 
Flavonifractor plautii 
(p=0.001) 




The dietary intake 




























on fecal samples: 







(cpa), beta (cpb), 
Clostridium perfringens 




↑ counts of Beta 2-Toxin 
gene-positive 
Clostridium perfringens 
in ASD vs HC (p=0.01) 
 
↑ incidence of Beta 2-
Toxin Clostridium 
perfringens in ASD vs 
HC (p=0.01) 
ASD severity is 
not indicated 
 
It is not indicated 




The dietary intake 
was not controlled 




beta 2 (cpb2), 




















10 males  
9 females 
Pyrosequencing of 





from the second 











for protein content 
No differences in 
microbiome diversity 
(alpha and beta) 
 
Burkholderia ↑ (p=0.03) 
and Neisseria ↓ (p=0.01) 
in ASD vs HC 
 
Bacteroides vulgatus ↓ 
(p=0.005), unidentified 
Bacteroides ↓ (p=0.04) 
and Escherichia coli ↓ 





Ralstonia ↑ (p<0.05) in 




Streptococcus ↓ (p<0.05) 
in ASD vs HC 
 
No differences in 
disaccharidase activity 
between groups 
↑ frequency of 





showed a strong positive 
correlation with lactase 
activity in ASD group 
 
Clostridium had a strong 
positive correlation with 
disaccharidase activity 
(lactase, maltase, 
palatinase and sucrose) 




and Leptotrichia had a 
strong positive 
correlation with lactase 
activity in HC group 
ASD severity is 
not indicated 
 
Is not indicated 





age and sex in 
study population 
and presence of 
various FGID in 
ASD and HC 
children.  
 
The role of diet 
and particularly 
dietary restrictions 
in ASD group 
remains a 
confusing factor 
in data analysis 


































time PCR in stool 
samples 
Bifidobacterium ↓ in 





Bifidobacterium ↑ and 








Severity of ASD 
symptoms ↓ (p=0.0001) 











Improvements in FGID 
correlated positively 
strongly with 
improvements in the 
severity of ASD 
symptoms after probiotic 




with decreased of body 
weight (p=0.044) and 
body weight z-score 
(p=0.033) after probiotic 
use 
 
↑ Lactobacilli correlated 
positively with the 
decrease in body weight 
(p=0.006) and the 
decreased of BMI 
(p=0.003) after probiotic 
use 
ASD severity is 
not indicated 
  
It is not indicated 
whether the ASD 
have intellectual 
disability 
A small sample 
size, unblinding 









































age and sex 
 
Selective culture 












identified with use 




BHI broth and 
GeneMATRIX 
DNA Purifi- 
cation Kit by 
DNA Gdansk for 
isolation of DN  
 
Multiplex PCR for 
toxin alpha (cpa), 
The cpa gene encoding 
alpha toxin was present 
in all 111 (100%) strains 
 
The cpb2 gene encoding 
beta2 toxin was found in: 
45/49 (91.8%) strains 
isolated from ASD 
children, 17/30 (56.7%) 
strains isolated from 
healthy subjects 
(p<0.001), and 12/32 
(37.5%) strains isolated 




strains with the ability to 
produce beta2 toxin 
(cpb2 gene) were 
detected in: 
27/29 (93.1%) ASD, 
10/17 (58.8%) HC 
(p<0.008), and 11/24 
(45.8%) obese children 
(p<0.001) 
 
No differences between 
HC and obese children 
(cpb2 and Clostridium 
perfringens with cpb2) 
 ASD severity is 
not indicated.  
 
Is not indicated 




A small number 
of studied patients 
and strains 














ASD w FGID 
(21/23) and 
ASD w/o 























the 16S rRNA 
gene bacterial 
(V2-V3 regions) 







Gut microbial diversity 
(alpha) ↓ (p<0.001) and 
relative abundances of 
phylotypes most closely 
related to Prevotella 




Haemophilus ↓ (p<0.05) 
in ASD vs NT 
 
Feacalibacterium 
prausnitzii ↓ (p<0.01) 
and Haemophilus 
parainfluenzae ↓ 
(p<0.05) in ASD vs NT 
 Isopropanol ↑ in ASD 
82% vs NT (p=0.022) 
 
p-cresol ↑ in ASD 26% 
vs NT (p=0.04) 
 
GABA trends ↓ in ASD 
(36%) vs NT (p=0.077) 
 
p-cresol concentrations 
were significantly and 
negatively correlated 





GI symptoms were 
significantly more severe 
for children with ASD 
compared to controls 
 
No correlation between 
all bacterial taxa and 
metabolites 
ASD severity is 
not indicated.  
 
Is not indicated 









enzymes could not 
be investigated) 
 







PICRUSt may be 
attributed to a 
difference in 
dataset types, a 









































Sequencing of the 
16S rRNA gene 
bacterial (V3 




Firmicutes ↑ in ASD vs 
HC Sib (p<0.05) 
 
Prevotellaceae ↓ and 
Veillonelleaceae ↑ in 




















No metabolites were 
studied 
 
It is not indicated 











Mirsuokella ↑ (p=0.007) 
in ASD vs HC Sib 
 
99% of Lactobacillus 
was Lactobacillus 





ASD w FGID 
(blood: n=20, 
15 males, 5 
females) 
(stool: n=21, 









25 males, 4 
females) 
 






















Age 3-12 y 
Sequencing of the 
16S rRNA gene 
bacterial (V3-V4 






1beta, IL-6, IL-12 
(p40 & p70), 
TNFalpha, IFNc 
(TH1), IL-4, IL-
13 (TH2), IL-10, 
TGFbeta1, IL-5, 
IL-15 and IL-17 
cytokines in 








Ruminococcaceae ↑ and 
Prevotellaceae ↑ in ASD 
w GI vs HC w GI 
 
Il-5, IL-15 and IL-17 ↑ 
in ASD w FGID vs ASD 
w/o FGID (after 
exposure to the TLR-4 
agonist LPS) 
 
TGFbeta1↓ in ASD w 
FGID vs ASD w/o FGID 
and HC w/o FGID 
(p<0.05) (under the 
majority of conditions 
examined) 
No correlation between 
cytokines levels or Hp 
and fecal microbiota 
 
Differences in the 
microbiome composition 
of children with ASD vs 
HC groups, irrespective 
of FGID 
ASD severity is 
not indicated.  
 
It is not indicated 





size and younger 
age of the HC 





ASD (n=11,  
9 males, 2 
females) 
Age 2-4 y 
 
HC (n=14, 
8 males, 6 
females) 
Age 2-4 y 
Sequencing of the 
16S rRNA gene 
bacterial (V3-V4 





































prausnitzii, B. uniformis, 
were positively 
correlated to the ADOS 
score (r=0.767 and r= 







eligens, were positively 
associated to butyrate 
level 
 
Butyrate ↑ (p=0.005) 





transferase alpha subunit 
gene ↑ (p<0.05) ASD vs 
HC 
 
Ruminococcus torques ↑, 
ASD severity is 
not indicated.  
 
It is not indicated 




A small number 
of studied patients 
and strains 





prausnitzii ↑, (p<0.05) 
 in ASD vs HC 
Beta-hexosaminidase 
(K12373) (>0.01%) ↑ 









Age 3-8 y 
HC (n=6, 5 
males, 1 
females) 
Age 3-8 y 
 
Sequencing of the 
16S rRNA gene 
bacterial (V3-V4 




ratio↑ in ASD w FGID 
vs HC (p<0.05) 
 
Bacteroidetes ↑ in ASD 
w FGID vs HC (p<0.05) 
 
Firmicutes ↓ in ASD w 







and Peptoniphilus ↓ in 




periodontitis and ASD 
 
Negative microbe-based 
link between type 1 
diabetes, constipation, 
IBS, psoriasis and ASD  
ASD severity is 
not indicated.  
 
It is not indicated 




A small number 







19 males, 7 
females) 




Age 2-7 y 
Sequencing of the 
16S rRNA gene 
bacterial (V3-V4 
regions) on fecal 
samples. 
 
Real time qPCR 











of VFA on fecal 
samples 








(p=0.005) in ASD vs HC 
 
Clostridium, Blautia, and 







Bilophila ↓ in ASD vs 
HC (p≤0.05)   
 
Bifidobacterium ↓ in 
ASD vs HC (p=0.04) 
  
C. perfringens ↓ in ASD 
vs HC (p=0.009) 
Intake of 
insoluble dietary fiber 
was negatively 
correlated (r=−0.4; 





with servings per day of 
fried food (r=0.43; 
p=0.0), but negatively 
correlated with servings 
per day of fruit (r=−0.39; 
p=0.05) 
ASD severity is 
not indicated.  
 
It is not indicated 
whether the ASD 
have intellectual 
disability 
Note: w = with; w/o = without; ASD = Autism Spectrum Disorder; HC = Healthy control; 
FGID = Functional Gastro-Intestinal Disorders; NT = Neurotypical; NT Sib = Neurotypical 
siblings; Sib = siblings; y = years; ADI = Autism Diagnostic Interview; DHEA-S = 
dehydroepiandrosteronesulfate; PDD-NOS = Pervasive Developmental Disorder Not 




Otherwise Specified; IBS = Irritable Bowel Syndrome; BMI = Body Mass Index, FAA = Free 











This article is protected by copyright. All rights reserved.
